Sinopia Biosciences, Inc.

About Sinopia Biosciences, Inc.

Sinopia Biosciences is a company focused on revolutionizing drug discovery through data-driven approaches. They aim to transform the study of diseases and the discovery of novel medicines by leveraging high-throughput multi-omics data, AI/machine learning, network analyses, and disease models. Their mission is to address high unmet clinical needs with first-in-class therapeutics.

Products & Services

LEADS(r) Platform:A platform that combines high-throughput screening, multi-omics data, AI/machine learning, and network analyses to identify novel targets and mechanisms for drug discovery. It is applied across multiple therapeutic areas.

Therapeutics Pipeline:Focused on developing first-in-class therapeutics in neurology, oncology, and genetic diseases, including a lead program for a novel chemical entity for Parkinson's disease.

Specialties

Data-Driven Drug Discovery (D4) Multi-Omics Data Analysis AI/Machine Learning Metabolomics High-Throughput Screening Neurology Oncology Genetic Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Phase II SBIR Grant T: - FT: Phase II SBIR Grant	A: 2200000 MR: - FA: $2.2M FAN: 2200000	D: 2024-09-12 FD: 2024-09-12	1 investors

Phase II SBIR Grant Latest

2024-09-12

$2.2M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David M. Weiner

MD

T

Tanya Simuni

Acting CMO

K

Kalpana Merchant

Scientific Advisory Board

M

Michael J. Fox

B

Bernhard O. Palsson

Y.C. Fung Endowed Professor in Bioengineering and Professor of Pediatrics

A

AJ

Board Member

View 11 more team members with Pro

Unlock Full Team Directory

Recent News